|
Media
Myth: Nine Worst Business Stories
(of the Last 50 Years)
5.
Silicone Breast Implants
Is increased self-esteem worth suffering
“flu-like symptoms,” “constant pain,” “extreme fatigue,” “fevers,”
“hair loss” and “bizarre skin rashes?” That’s the question Connie
Chung posed in 1990 in a glaring attack on silicone breast implants
that led to a ban on the product for most consumers. “Most of us know little about breast implants.
We’ve seen the ads. We’ve heard the rumors about which celebrities
have them and which don’t. But we don’t know anything about the
dangers,” Chung said in the introduction for her segment.
On her CBS show “Face to Face” Dec. 10, 1990,
Chung featured five women who claimed to be victims of faulty
silicone implants. According to the women, their implants had leaked
into their body tissue, causing what one woman called
“silicone-associated disease.”
Chung noted that one of the women, Karen Bollea,
suffered from achy joints, extreme fatigue, hair loss and skin
rashes, among other symptoms. Chung also noted that Bollea would
later be diagnosed with Lupus, a disease with symptoms including
achy joints, extreme fatigue, hair loss and skin rashes. Chung
implied that that symptoms were caused by Bollea’s implants.
“We have done a large-scale clinical experiment
on an unproven, probably unsafe medical device,” Dr. Douglas
Shanklin of the University of Tennessee said in the report. Chung
displayed graphic images of “mangled and infected” breasts, the
result of multiple surgeries to replace and remove implants.
The segment featured five women and two doctors
who alleged that silicone was connected to tissue disease. She noted
that Surgitek, the maker of a silicone implant, and the Food and
Drug Administration both declined to comment. About 26 seconds of
the more than 12-minute segment focused on their side of the story.
The Food and Drug Administration was already
investigating complaints about silicone implants, according to
Chung. But her report led to increased attention to the research as
well as congressional investigations.
The FDA banned silicone implants in April 1992
when it said manufacturers couldn’t come up with enough proof that
they were safe. But the ban applied only to cosmetic implants. Women
who had undergone mastectomies could still obtain them. The decision
implied that the FDA didn’t consider silicone so dangerous that it
warranted a full ban.
On Nov. 17, 2006, the
FDA lifted the partial ban on silicone, calling the implants
“safe and effective.” The agency reported that some complications
existed in studies of the implants but that “the majority of women
in these studies reported being satisfied.”
“In the past decade, a number of independent
studies have examined whether silicone gel-filled breast implants
are associated with connective tissue disease or cancer,” the agency
said. “The studies, including a report by the Institute of Medicine,
have concluded there is no convincing evidence that breast implants
are associated with either of these diseases.”
In the time between Chung’s “Face to Face”
report and the FDA deeming the implants safe, however, businesses
were on the chopping block. A “flood” of lawsuits followed the ban,
according to a June 1996 article in the New England Journal of
Medicine. One Texas woman received a $25-million settlement. NBC
later reported that “thousands of women won billions of dollars in
lawsuits.”
Dow Corning, a major manufacturer of silicone
implants,
filed for bankruptcy in 1995 as a result of the overwhelming
number of lawsuits. It didn’t come out of bankruptcy until
nine years later, in June 2004.
And while women who had lost breasts to
mastectomies were allowed the implants during the FDA’s 14-year
testing period, women who wanted the products for cosmetic reasons
faced tough restrictions, despite FDA surveys showing a majority of
women wanted them on the market with knowledge of potential risks.
Even after the FDA exonerated silicone, the
media couldn’t let go of the myth that it was widely dangerous.
NBC anchor Brian Williams reported on Nov. 17, 2006, that “a lot of
people are going to have a hard time with the government blessing
for this particular product, being a foreign substance being sewn
inside the bodies of women.” He didn’t mention other “foreign
substances” sewn into patients’ bodies routinely,
like pacemakers.
While the FDA statement clearly said there was
“no convincing evidence” that implants were dangerous, Katie Couric
declared in a Nov. 17, 2006, “CBS Evening News” report that “there
are still safety concerns.”
The Washington Post led its November 18 story
saying the ban was lifted “despite lingering safety concerns from
some health advocates.” The “health advocates” were Diana Zuckerman,
president of the National Research Center for Women and Families,
and Susan Wood, a former FDA official who, ironically enough,
quit in 2005 because the agency took too long to approve the “Plan
B” morning-after pill. It appeared that to Wood, 14 years of
study weren’t enough to prove silicone was safe, but Wood was
willing to quit her job because the FDA wanted more than two years
to study Plan B’s safety.
The New York Times at the same time quoted Dr.
Sidney Wolfe of the anti-business, pro-regulation Public Citizen,
who insisted that implants were “the most defective medical device
ever approved by the FDA.”
In
2007, the first full year following the lifting of the ban, American
plastic surgeons performed 347,524 breast augmentations, with
silicone accounting for 35 percent – more than 121,600 – of the
augmentations,
according to the American Society of Plastic Surgeons. For
comparison,
in 1994, the first year after the ban for which the ASPS
provides statistics, only 6 percent of breast augmentations used
gel-based implants.
Back to main page.
|